Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylguanine methyltransferase (MGMT) is an essential nuclear enzyme responsible for direct reversal repair of toxic/mutagenic O^6-methylguanine lesions on DNA—a process crucial both for maintaining genomic integrity under normal conditions and determining tumor sensitivity/resistance during chemotherapy with alkylating agents.
Direct reversal of O^6-methylguanine lesions via alkyl group transfer to a cysteine residue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on O^6-methylguanine-DNA methyltransferase (MGMT).